S. 1674 (111th): Improving Access to Clinical Trials Act of 2009

Sep 15, 2009 (111th Congress, 2009–2010)
Signed by the President
Slip Law:
This bill became Pub.L. 111-255.
Ron Wyden
Senator from Oregon
Read Text »
Last Updated
Sep 24, 2010
3 pages
Related Bills
H.R. 2866 (Related)
Improving Access to Clinical Trials Act of 2009

Referred to Committee
Last Action: Jun 15, 2009


This bill was enacted after being signed by the President on October 5, 2010.

Introduced Sep 15, 2009
Referred to Committee Sep 15, 2009
Passed Senate Aug 05, 2010
Passed House Sep 23, 2010
Signed by the President Oct 05, 2010
Full Title

A bill to provide for an exclusion under the Supplemental Security Income program and the Medicaid program for compensation provided to individuals who participate in clinical trials for rare diseases or conditions.


No summaries available.

21 cosponsors (14D, 7R) (show)

Senate Finance

The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


S. stands for Senate bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

10/5/2010--Public Law.
(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Improving Access to Clinical Trials Act of 2009 - Amends title XVI (Supplemental Security Income) (SSI) of the Social Security Act (SSA) to exclude from income for SSI eligibility purposes any compensation in the amount of the first $2,000 per year received by an individual for participation in clinical trials involving research and testing of treatments for rare diseases or conditions.
Amends SSA title XIX (Medicaid) to make a similar exclusion from income of such compensation for the purposes of eligibility under the Medicaid program.
Directs the Comptroller General to study and report to Congress on the impact of this Act on enrollment of individuals who receive SSI benefits in clinical trials for rare diseases or conditions.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of S. 1674 (111th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus